Date published: 2026-4-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

DYNLL1 Inhibitors

DYNLL1 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the DYNLL1 protein, also known as dynein light chain LC8-type 1. DYNLL1 is a small, highly conserved protein that plays a critical role in a variety of cellular processes, particularly those related to intracellular transport, cell division, and the regulation of signaling pathways. As a component of the dynein motor complex, DYNLL1 is involved in the transport of various cellular cargos along microtubules, including organelles, vesicles, and proteins. Additionally, DYNLL1 interacts with a wide range of binding partners, functioning as a versatile adaptor protein that can influence the stability, localization, and activity of these partners. This protein is also implicated in the regulation of apoptosis, where it interacts with pro-apoptotic factors, modulating their activity and the cellular response to stress. Inhibitors of DYNLL1 function by binding to specific regions of the protein, particularly those involved in its interactions with other proteins or its role in the dynein motor complex. By inhibiting DYNLL1, these compounds can disrupt its ability to mediate intracellular transport and affect the various signaling pathways that depend on its interactions. This inhibition may lead to a range of cellular effects, such as impaired organelle movement, altered cell division, and changes in the regulation of apoptosis. Moreover, DYNLL1 inhibitors might impact the protein's ability to act as a scaffolding component in signaling complexes, potentially affecting processes like cell migration, DNA repair, and gene expression regulation. Understanding the effects of DYNLL1 inhibition provides valuable insights into the role of this protein in maintaining cellular organization and function. This knowledge is crucial for exploring how DYNLL1 contributes to the intricate network of cellular processes that ensure proper cellular function and response to environmental changes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ciliobrevin D

1370554-01-0sc-507482
10 mg
$413.00
(0)

Ciliobrevin D is an inhibitor of dynein, indirectly modulating DYNLL1 by disrupting the dynein-mediated transport processes in the cell, affecting DYNLL1 localization and function.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore inhibits dynamin, affecting endocytosis. Since DYNLL1 is involved in endocytic processes, Dynasore indirectly influences DYNLL1 function by disrupting endocytosis and related cellular processes.

CC-401

395104-30-0sc-364748
sc-364748A
2 mg
10 mg
$331.00
$1060.00
4
(1)

CC-401, a receptor tyrosine kinase (RTK) inhibitor, can indirectly modulate DYNLL1 by affecting signaling pathways associated with RTKs that regulate DYNLL1 function.

Ro 31-8220

138489-18-6sc-200619
sc-200619A
1 mg
5 mg
$92.00
$245.00
17
(1)

Ro 31-8220 is a pan-PKC (protein kinase C) inhibitor that can indirectly modulate DYNLL1 by affecting PKC-mediated signaling pathways associated with DYNLL1 regulation.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$91.00
$267.00
13
(1)

ML7 is a myosin light chain kinase (MLCK) inhibitor that can indirectly modulate DYNLL1 by affecting the actin cytoskeleton and related cellular processes.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a selective inhibitor of p38 MAPK, indirectly influencing DYNLL1 by disrupting the p38 MAPK signaling pathway associated with DYNLL1 regulation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, can indirectly modulate DYNLL1 by affecting the PI3K/Akt signaling pathway, which is implicated in DYNLL1-related cellular processes.

Tyrphostin AG 879

148741-30-4sc-3557
sc-3557A
5 mg
25 mg
$83.00
$328.00
4
(1)

AG-879 is a tyrosine kinase inhibitor, indirectly modulating DYNLL1 by affecting signaling pathways related to tyrosine kinases involved in DYNLL1 regulation.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$65.00
$261.00
113
(3)

3-Methyladenine is an inhibitor of autophagy, impacting DYNLL1 by influencing the autophagic processes in which DYNLL1 is involved.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a selective JNK (c-Jun N-terminal kinase) inhibitor that can indirectly modulate DYNLL1 by disrupting the JNK signaling pathway associated with DYNLL1 regulation.